Literature DB >> 11100979

Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.

R Nakaoke1, S Sakaguchi, R Atarashi, N Nishida, K Arima, K Shigematsu, S Katamine.   

Abstract

1. To elucidate mechanisms for the generation of the detergent-insoluble, proteinase K-resistant prion protein (PrP(Sc)) from the detergent-soluble, proteinase K-sensitive PrP (PrP(C)) and the replication of the infectious agent in prion diseases, we followed the kinetics of detergent-insoluble PrP and PrP(Sc) levels, infectious titers, and associated pathological changes in the brains of mice inoculated with a mouse-adapted Creutzfeldt Jakob disease agent. 2. PrP(Sc) in brain homogenate and detergent-insoluble PrP enriched by two-cycle ultracentrifugation were detected by immunoblotting and their relative amounts were estimated according to a standard curve plotted between the amount of PrP and signal intensity on immunoblotting. The titer of infectivity was determined by the incubation periods of mice inoculated with the unfractionated homogenate on the basis of a standard curve plotted between the titer and incubation period. 3. Detergent-insoluble PrP became detectable 4 weeks postinoculation (p.i.) well before the detection of PrP(Sc). The low level of detergent-insoluble PrP continued until dramatic accumulation occurred at 14 weeks p.i., correlating well with the accumulation of PrP(Sc) and development of pathological changes. The infectious titer was undetectable at 4 weeks p.i. and its logarithmic increase occurred 10 weeks p.i. preceding the logarithmic accumulation of PrPs. 4. The lag time of detergent-insoluble PrP accumulation and the discrepancy between infectious titers and PrPs observed during the early period after inoculation suggest a slow and rate-limiting step for the detergent-insoluble PrP to become the infectious agent-associated PrP(Sc).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11100979     DOI: 10.1023/a:1007054909662

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  29 in total

1.  Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease.

Authors:  J Kopacek; S Sakaguchi; K Shigematsu; N Nishida; R Atarashi; R Nakaoke; R Moriuchi; M Niwa; S Katamine
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  A 'unified theory' of prion propagation.

Authors:  C Weissmann
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

3.  Structural clues to prion replication.

Authors:  F E Cohen; K M Pan; Z Huang; M Baldwin; R J Fletterick; S B Prusiner
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

4.  A mouse prion protein transgene rescues mice deficient for the prion protein gene from purkinje cell degeneration and demyelination.

Authors:  N Nishida; P Tremblay; T Sugimoto; K Shigematsu; S Shirabe; C Petromilli; S P Erpel; R Nakaoke; R Atarashi; T Houtani; M Torchia; S Sakaguchi; S J DeArmond; S B Prusiner; S Katamine
Journal:  Lab Invest       Date:  1999-06       Impact factor: 5.662

5.  Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells.

Authors:  S Lehmann; D A Harris
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

6.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

7.  Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice.

Authors:  S Sakaguchi; S Katamine; K Yamanouchi; M Kishikawa; R Moriuchi; N Yasukawa; T Doi; T Miyamoto
Journal:  J Gen Virol       Date:  1993-10       Impact factor: 3.891

8.  Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents.

Authors:  J Tateishi; M Ohta; M Koga; Y Sato; Y Kuroiwa
Journal:  Ann Neurol       Date:  1979-06       Impact factor: 10.422

9.  Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation.

Authors:  Y G Xi; L Ingrosso; A Ladogana; C Masullo; M Pocchiari
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

Review 10.  Biology and genetics of prion diseases.

Authors:  S B Prusiner
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

View more
  5 in total

Review 1.  In vitro methods in the study of viral and prion permeability across the blood-brain barrier.

Authors:  Ryota Nakaoke; William A Banks
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

2.  Failure to detect abnormal prion protein and scrapie-associated fibrils 6 wk after intracerebral inoculation of genetically susceptible sheep with scrapie agent.

Authors:  Amir N Hamir; Janice M Miller; Mick J Stack; Melanie J Chaplin
Journal:  Can J Vet Res       Date:  2002-10       Impact factor: 1.310

3.  Efficient transmission of two different sheep scrapie isolates in transgenic mice expressing the ovine PrP gene.

Authors:  C Crozet; F Flamant; A Bencsik; D Aubert; J Samarut; T Baron
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 4.  Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?

Authors:  Angélique Igel-Egalon; Jan Bohl; Mohammed Moudjou; Laetitia Herzog; Fabienne Reine; Human Rezaei; Vincent Béringue
Journal:  Viruses       Date:  2019-05-10       Impact factor: 5.048

5.  Early stage prion assembly involves two subpopulations with different quaternary structures and a secondary templating pathway.

Authors:  Angélique Igel-Egalon; Florent Laferrière; Mohammed Moudjou; Human Rezaei; Vincent Béringue; Jan Bohl; Mathieu Mezache; Tina Knäpple; Laetitia Herzog; Fabienne Reine; Christelle Jas-Duval; Marie Doumic
Journal:  Commun Biol       Date:  2019-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.